Bioinformatics Services Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)

Description

Key Drivers Fueling Growth in Bioinformatics Services Market

The global bioinformatics services market is poised for substantial growth, with projections indicating a Compound Annual Growth Rate (CAGR) of 14 % from USD 3.5 Billion in 2024 to USD 8.7 Billion by 2031. The burgeoning demand for bioinformatics services across various industries, coupled with reduced sequencing costs and the increasing prevalence of chronic diseases, are key factors propelling market expansion.

Growing Applications of Bioinformatics in Diverse Industries

Bioinformatics services are witnessing growing adoption in an array of industries including food, bioremediation, agriculture, forensics, and consumer goods. Companies are leveraging services such as data analysis, gene expression, sequencing, and database administration to enhance product quality and streamline supply chain operations. This expanding application landscape is expected to drive overall market growth significantly.

Cost Reductions in Genome Sequencing

Technological advancements have led to substantial reductions in genome sequencing costs. The availability of efficient and cost-effective sequencing technologies has spurred global adoption, fueling growth in the bioinformatics services market. The accessibility of modern sequencing systems at lower costs has facilitated widespread utilization across various sectors, contributing to market expansion.

Rising Incidence of Chronic Diseases and Aging Population

The escalating prevalence of chronic diseases alongside the global aging population is another driving force behind the growth of the bioinformatics services market. The increasing demand for therapeutic drugs to address chronic conditions is expected to boost market growth as bioinformatics services play a crucial role in drug discovery and development processes.

Enhanced Collaboration between IT and Pharmaceuticals

Collaborations between information technology (IT) firms and pharmaceutical companies are on the rise, driving innovation in essential healthcare technologies. These partnerships are fostering advancements in cloud computing and other areas, thereby stimulating growth in the bioinformatics services market. The synergistic efforts between IT and pharma companies are anticipated to further propel market expansion in the forecast period.

Challenges: Addressing Data Complexity

Despite the promising growth outlook, challenges persist, notably in handling the complexity of biological data. The proliferation of biological experiments has led to a data explosion, necessitating advanced infrastructure for data processing, storage, retrieval, and analysis. Addressing these complexities poses significant challenges for bioinformatics service providers and may hinder market growth.

Impact of COVID-19 on Bioinformatics Services Market

During the COVID-19 pandemic, bioinformatics played a pivotal role in understanding and combating the virus. Researchers leveraged bioinformatics capabilities to decode the coronavirus genome, enabling the development of vaccines and diagnostic tools. The superior capabilities of bioinformatics service providers facilitated crucial insights into the characteristics of SARS-CoV-2, aiding in the global response to the pandemic.

Competitive Analysis

The bioinformatics services market is highly competitive, with major players driving innovation and efficiency in drug development processes. Key players are increasingly focusing on in-house solutions to reduce costs and enhance workflow efficiency, further intensifying competition in the market.

Key Companies Profiled

Illumina, Inc.
Thermo Fisher Scientific
Strand Life Sciences, Inc.
CD Genomics
Biomax Informatics AG
DNANEXUS, INC.
Agilent Technologies, Inc.
QIAGEN N.V.
Gene Codes Corporation
BGI Group
Gene Code Corporation
PerkinElmer Inc.
Premier Biosoft
Biomatters Geneious
Creative-Biolabs
DNASTAR
GSL Biotech LLC (SnapGene)
FIOS Genomics

Bioinformatics Services Market Categorization

Bioinformatics Services Market by Service Type

Drug Development
Molecular Medicine
Microbial Genome Applications
Gene Therapy
Veterinary Science
Forensic Analysis
Others

Bioinformatics Services Market by Application

Sequencing
Data Storage and Managemen
Data Analysis
Drug Discovery
Others

Bioinformatics Services Market by End User

Academics and Research Centers
Pharmaceutical and Biotechnology Industries
Forensics Laboratories
Others

Bioinformatics Services Market by Region

North America
Latin America
Europe
Asia Pacific
Middle East & Africa (MEA)

1. Executive Summary

1.1. Global Bioinformatics Services Market Snapshot
1.2. Future Projections
1.3. Key Market Trends
1.4. Regional Snapshot, by Value, 2023
1.5. Analyst Recommendations

2. Market Overview

2.1. Market Definitions and Segmentations
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
2.3. Value Chain Analysis
2.4. Porter's Five Forces Analysis
2.5. COVID-19 Impact Analysis
- 2.5.1. Supply
- 2.5.2. Demand
2.6. Impact of Ukraine-Russia Conflict
2.7. Economic Overview
- 2.7.1. World Economic Projections
2.8. PESTLE Analysis

3. Global Bioinformatics Services Market Outlook, 2018 - 2031

3.1. Global Bioinformatics Services Market Outlook, by Service Type, Value (US$ Bn), 2018 - 2031
- 3.1.1. Key Highlights
  - 3.1.1.1. Drug Development
  - 3.1.1.2. Molecular Medicine
  - 3.1.1.3. Microbial Genome Applications
  - 3.1.1.4. Gene Therapy
  - 3.1.1.5. Veterinary Science
  - 3.1.1.6. Forensic Analysis
  - 3.1.1.7. Others
3.2. Global Bioinformatics Services Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 3.2.1. Key Highlights
  - 3.2.1.1. Sequencing
  - 3.2.1.2. Data Storage and Managemen
  - 3.2.1.3. Data Analysis
  - 3.2.1.4. Drug Discovery
  - 3.2.1.5. Others
3.3. Global Bioinformatics Services Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 3.3.1. Key Highlights
  - 3.3.1.1. Academics and Research Centers
  - 3.3.1.2. Pharmaceutical and Biotechnology Industries
  - 3.3.1.3. Forensics Laboratories
  - 3.3.1.4. Others
3.4. Global Bioinformatics Services Market Outlook, by Region, Value (US$ Bn), 2018 - 2031
- 3.4.1. Key Highlights
  - 3.4.1.1. North America
  - 3.4.1.2. Europe
  - 3.4.1.3. Asia Pacific
  - 3.4.1.4. Latin America
  - 3.4.1.5. Middle East & Africa

4. North America Bioinformatics Services Market Outlook, 2018 - 2031

4.1. North America Bioinformatics Services Market Outlook, by Service Type, Value (US$ Bn), 2018 - 2031
- 4.1.1. Key Highlights
  - 4.1.1.1. Drug Development
  - 4.1.1.2. Molecular Medicine
  - 4.1.1.3. Microbial Genome Applications
  - 4.1.1.4. Gene Therapy
  - 4.1.1.5. Veterinary Science
  - 4.1.1.6. Forensic Analysis
  - 4.1.1.7. Others
4.2. North America Bioinformatics Services Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 4.2.1. Key Highlights
  - 4.2.1.1. Sequencing
  - 4.2.1.2. Data Storage and Managemen
  - 4.2.1.3. Data Analysis
  - 4.2.1.4. Drug Discovery
  - 4.2.1.5. Others
4.3. North America Bioinformatics Services Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 4.3.1. Key Highlights
  - 4.3.1.1. Academics and Research Centers
  - 4.3.1.2. Pharmaceutical and Biotechnology Industries
  - 4.3.1.3. Forensics Laboratories
  - 4.3.1.4. Others
- 4.3.2. BPS Analysis/Market Attractiveness Analysis
4.4. North America Bioinformatics Services Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 4.4.1. Key Highlights
  - 4.4.1.1. U.S. Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.2. U.S. Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.3. U.S. Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 4.4.1.4. Canada Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 4.4.1.5. Canada Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 4.4.1.6. Canada Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
- 4.4.2. BPS Analysis/Market Attractiveness Analysis

5. Europe Bioinformatics Services Market Outlook, 2018 - 2031

5.1. Europe Bioinformatics Services Market Outlook, by Service Type, Value (US$ Bn), 2018 - 2031
- 5.1.1. Key Highlights
  - 5.1.1.1. Drug Development
  - 5.1.1.2. Molecular Medicine
  - 5.1.1.3. Microbial Genome Applications
  - 5.1.1.4. Gene Therapy
  - 5.1.1.5. Veterinary Science
  - 5.1.1.6. Forensic Analysis
  - 5.1.1.7. Others
5.2. Europe Bioinformatics Services Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 5.2.1. Key Highlights
  - 5.2.1.1. Sequencing
  - 5.2.1.2. Data Storage and Managemen
  - 5.2.1.3. Data Analysis
  - 5.2.1.4. Drug Discovery
  - 5.2.1.5. Others
5.3. Europe Bioinformatics Services Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 5.3.1. Key Highlights
  - 5.3.1.1. Academics and Research Centers
  - 5.3.1.2. Pharmaceutical and Biotechnology Industries
  - 5.3.1.3. Forensics Laboratories
  - 5.3.1.4. Others
- 5.3.2. BPS Analysis/Market Attractiveness Analysis
5.4. Europe Bioinformatics Services Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 5.4.1. Key Highlights
  - 5.4.1.1. Germany Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.2. Germany Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.3. Germany Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.4. U.K. Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.5. U.K. Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.6. U.K. Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.7. France Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.8. France Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.9. France Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.10. Italy Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.11. Italy Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.12. Italy Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.13. Turkey Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.14. Turkey Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.15. Turkey Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.16. Russia Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.17. Russia Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.18. Russia Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 5.4.1.19. Rest of Europe Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 5.4.1.20. Rest of Europe Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 5.4.1.21. Rest of Europe Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
- 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Asia Pacific Bioinformatics Services Market Outlook, 2018 - 2031

6.1. Asia Pacific Bioinformatics Services Market Outlook, by Service Type, Value (US$ Bn), 2018 - 2031
- 6.1.1. Key Highlights
  - 6.1.1.1. Drug Development
  - 6.1.1.2. Molecular Medicine
  - 6.1.1.3. Microbial Genome Applications
  - 6.1.1.4. Gene Therapy
  - 6.1.1.5. Veterinary Science
  - 6.1.1.6. Forensic Analysis
  - 6.1.1.7. Others
6.2. Asia Pacific Bioinformatics Services Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 6.2.1. Key Highlights
  - 6.2.1.1. Sequencing
  - 6.2.1.2. Data Storage and Managemen
  - 6.2.1.3. Data Analysis
  - 6.2.1.4. Drug Discovery
  - 6.2.1.5. Others
6.3. Asia Pacific Bioinformatics Services Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 6.3.1. Key Highlights
  - 6.3.1.1. Academics and Research Centers
  - 6.3.1.2. Pharmaceutical and Biotechnology Industries
  - 6.3.1.3. Forensics Laboratories
  - 6.3.1.4. Others
- 6.3.2. BPS Analysis/Market Attractiveness Analysis
6.4. Asia Pacific Bioinformatics Services Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 6.4.1. Key Highlights
  - 6.4.1.1. China Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.2. China Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.3. China Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.4. Japan Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.5. Japan Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.6. Japan Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.7. South Korea Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.8. South Korea Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.9. South Korea Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.10. India Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.11. India Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.12. India Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.13. Southeast Asia Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.14. Southeast Asia Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.15. Southeast Asia Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 6.4.1.16. Rest of Asia Pacific Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 6.4.1.17. Rest of Asia Pacific Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 6.4.1.18. Rest of Asia Pacific Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
- 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Latin America Bioinformatics Services Market Outlook, 2018 - 2031

7.1. Latin America Bioinformatics Services Market Outlook, by Service Type, Value (US$ Bn), 2018 - 2031
- 7.1.1. Key Highlights
  - 7.1.1.1. Drug Development
  - 7.1.1.2. Molecular Medicine
  - 7.1.1.3. Microbial Genome Applications
  - 7.1.1.4. Gene Therapy
  - 7.1.1.5. Veterinary Science
  - 7.1.1.6. Forensic Analysis
  - 7.1.1.7. Others
7.2. Latin America Bioinformatics Services Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 7.2.1. Key Highlights
  - 7.2.1.1. Sequencing
  - 7.2.1.2. Data Storage and Managemen
  - 7.2.1.3. Data Analysis
  - 7.2.1.4. Drug Discovery
  - 7.2.1.5. Others
7.3. Latin America Bioinformatics Services Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 7.3.1. Key Highlights
  - 7.3.1.1. Academics and Research Centers
  - 7.3.1.2. Pharmaceutical and Biotechnology Industries
  - 7.3.1.3. Forensics Laboratories
  - 7.3.1.4. Others
- 7.3.2. BPS Analysis/Market Attractiveness Analysis
7.4. Latin America Bioinformatics Services Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 7.4.1. Key Highlights
  - 7.4.1.1. Brazil Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.2. Brazil Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.3. Brazil Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.4. Mexico Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.5. Mexico Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.6. Mexico Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.7. Argentina Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.8. Argentina Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.9. Argentina Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 7.4.1.10. Rest of Latin America Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 7.4.1.11. Rest of Latin America Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 7.4.1.12. Rest of Latin America Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
- 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Middle East & Africa Bioinformatics Services Market Outlook, 2018 - 2031

8.1. Middle East & Africa Bioinformatics Services Market Outlook, by Service Type, Value (US$ Bn), 2018 - 2031
- 8.1.1. Key Highlights
  - 8.1.1.1. Drug Development
  - 8.1.1.2. Molecular Medicine
  - 8.1.1.3. Microbial Genome Applications
  - 8.1.1.4. Gene Therapy
  - 8.1.1.5. Veterinary Science
  - 8.1.1.6. Forensic Analysis
  - 8.1.1.7. Others
8.2. Middle East & Africa Bioinformatics Services Market Outlook, by Application, Value (US$ Bn), 2018 - 2031
- 8.2.1. Key Highlights
  - 8.2.1.1. Sequencing
  - 8.2.1.2. Data Storage and Managemen
  - 8.2.1.3. Data Analysis
  - 8.2.1.4. Drug Discovery
  - 8.2.1.5. Others
8.3. Middle East & Africa Bioinformatics Services Market Outlook, by End User, Value (US$ Bn), 2018 - 2031
- 8.3.1. Key Highlights
  - 8.3.1.1. Academics and Research Centers
  - 8.3.1.2. Pharmaceutical and Biotechnology Industries
  - 8.3.1.3. Forensics Laboratories
  - 8.3.1.4. Others
- 8.3.2. BPS Analysis/Market Attractiveness Analysis
8.4. Middle East & Africa Bioinformatics Services Market Outlook, by Country, Value (US$ Bn), 2018 - 2031
- 8.4.1. Key Highlights
  - 8.4.1.1. GCC Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.2. GCC Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.3. GCC Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.4. South Africa Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.5. South Africa Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.6. South Africa Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.7. Egypt Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.8. Egypt Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.9. Egypt Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.10. Nigeria Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.11. Nigeria Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.12. Nigeria Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
  - 8.4.1.13. Rest of Middle East & Africa Bioinformatics Services Market by Service Type, Value (US$ Bn), 2018 - 2031
  - 8.4.1.14. Rest of Middle East & Africa Bioinformatics Services Market by Application, Value (US$ Bn), 2018 - 2031
  - 8.4.1.15. Rest of Middle East & Africa Bioinformatics Services Market by End User, Value (US$ Bn), 2018 - 2031
- 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Competitive Landscape

9.1. Service Type vs Application Heatmap
9.2. Company Market Share Analysis, 2023
9.3. Competitive Dashboard
9.4. Company Profiles
- 9.4.1. Illumina, Inc.
  - 9.4.1.1. Company Overview
  - 9.4.1.2. Product Portfolio
  - 9.4.1.3. Financial Overview
  - 9.4.1.4. Business Strategies and Development
- 9.4.2. Thermo Fisher Scientific
  - 9.4.2.1. Company Overview
  - 9.4.2.2. Product Portfolio
  - 9.4.2.3. Financial Overview
  - 9.4.2.4. Business Strategies and Development
- 9.4.3. Strand Life Sciences, Inc.
  - 9.4.3.1. Company Overview
  - 9.4.3.2. Product Portfolio
  - 9.4.3.3. Financial Overview
  - 9.4.3.4. Business Strategies and Development
- 9.4.4. CD Genomics
  - 9.4.4.1. Company Overview
  - 9.4.4.2. Product Portfolio
  - 9.4.4.3. Financial Overview
  - 9.4.4.4. Business Strategies and Development
- 9.4.5. Biomax Informatics AG
  - 9.4.5.1. Company Overview
  - 9.4.5.2. Product Portfolio
  - 9.4.5.3. Financial Overview
  - 9.4.5.4. Business Strategies and Development
- 9.4.6. DNANEXUS, INC.
  - 9.4.6.1. Company Overview
  - 9.4.6.2. Product Portfolio
  - 9.4.6.3. Financial Overview
  - 9.4.6.4. Business Strategies and Development
- 9.4.7. Agilent Technologies, Inc.
  - 9.4.7.1. Company Overview
  - 9.4.7.2. Product Portfolio
  - 9.4.7.3. Financial Overview
  - 9.4.7.4. Business Strategies and Development
- 9.4.8. QIAGEN N.V.
  - 9.4.8.1. Company Overview
  - 9.4.8.2. Product Portfolio
  - 9.4.8.3. Financial Overview
  - 9.4.8.4. Business Strategies and Development
- 9.4.9. Gene Codes Corporation
  - 9.4.9.1. Company Overview
  - 9.4.9.2. Product Portfolio
  - 9.4.9.3. Financial Overview
  - 9.4.9.4. Business Strategies and Development
- 9.4.10. BGI Group
  - 9.4.10.1. Company Overview
  - 9.4.10.2. Product Portfolio
  - 9.4.10.3. Financial Overview
  - 9.4.10.4. Business Strategies and Development
- 9.4.11. Gene Code Corporation
  - 9.4.11.1. Company Overview
  - 9.4.11.2. Product Portfolio
  - 9.4.11.3. Financial Overview
  - 9.4.11.4. Business Strategies and Development
- 9.4.12. PerkinElmer Inc.
  - 9.4.12.1. Company Overview
  - 9.4.12.2. Product Portfolio
  - 9.4.12.3. Financial Overview
  - 9.4.12.4. Business Strategies and Development
- 9.4.13. Premier Biosoft
  - 9.4.13.1. Company Overview
  - 9.4.13.2. Product Portfolio
  - 9.4.13.3. Financial Overview
  - 9.4.13.4. Business Strategies and Development

10. Appendix

10.1. Research Methodology
10.2. Report Assumptions
10.3. Acronyms and Abbreviations